消岩汤联合甲磺酸阿帕替尼治疗晚期胃癌的回顾性研究

《消岩汤联合甲磺酸阿帕替尼治疗晚期胃癌的回顾性研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、学校代码：10063专业代码：105701二〇一八届硕士研究生毕业暨学位论文消岩汤联合甲磺酸阿帕替尼治疗晚期胃癌的回顾性研究AretrospectivestudyontreatmentofXiaoyantangcombinedApatinibtreatingadvancedgastriccancer专业：中医内科学学位类型：专业学位研究生：石文君指导教师：陈军主任医师天津中医药大学二〇一八年五月天津中医药大学硕士学位论文目录中文摘要..............................................

2、.......................................................................................1ABSTRACT................................................................................................................................3英文缩略词表.................................

3、............................................................................................5前言.............................................................................................................................................6消岩汤联合阿帕替尼治疗晚期胃癌的回顾性临床研究....

4、.....................................................81.临床资料..............................................................................................................................81.1病例来源......................................................................

5、.................................................81.2病例选择......................................................................................................................82.试验方法..................................................................................

6、............................................92.1分组治疗方案...............................................................................................................92.2观察项目...........................................................................................

7、............................92.3疗效评价.....................................................................................................................102.4不良反应评估....................................................................................................

8、.........112.5统计学方法.................................................................................................................113.患者基线资料..........